ONA Navigation Summit 2016 Live Coverage
Food speaks to our genes; its message or signal can turn the immune system on or off. Consumption of a high carbohydrate or sugar diet can increase risk of cancer.
Navigator-specific Interventions and Multidisciplinary Care Team Collaboration Improves Care and Outcomes for Patients with GI Cancers
The GI ONN is a relatively new position whose role is not only to remove barriers to care, but also to facilitate timely, comprehensive, and evidence-based care for patients with GI cancers.
A navigation process that effectively addresses a community's health care disparities and barriers to cancer care is driven by a triennial Community Health Needs Assessment (CHNA).
Oncology rehabilitation is cost-effective; it lowers both direct and indirect health care costs and improves physical and psychological quality of life for patients with cancer.
A working knowledge of frailty, multimorbidity, and geriatric syndromes, as well as self-awareness of and sensitivity to ageism are key skills for oncology navigators caring for older patients.
Navigators need to be aware of the signs and symptoms of cognitive and emotional distress and be able to determine which patients and family members need to be managed more closely.
Patient navigation ensures patients with cancer achieve diagnostic resolution in a timely manner, leading to optimal outcomes for both patients and the community.
Side effects are defined as long-term or late. Although the 2 types are difficult to distinguish, their distinction is both clear and important.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|